BR112022012216A2 - Formulação de cuidado de saúde sólida, formulação líquida para cuidado de saúde, e emulsão para cuidados de saúde - Google Patents

Formulação de cuidado de saúde sólida, formulação líquida para cuidado de saúde, e emulsão para cuidados de saúde

Info

Publication number
BR112022012216A2
BR112022012216A2 BR112022012216A BR112022012216A BR112022012216A2 BR 112022012216 A2 BR112022012216 A2 BR 112022012216A2 BR 112022012216 A BR112022012216 A BR 112022012216A BR 112022012216 A BR112022012216 A BR 112022012216A BR 112022012216 A2 BR112022012216 A2 BR 112022012216A2
Authority
BR
Brazil
Prior art keywords
healthcare
formulation
formulations
active
emulsion
Prior art date
Application number
BR112022012216A
Other languages
English (en)
Inventor
Asirvatham Edward
Original Assignee
Advansix Resins & Chemicals Llc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Advansix Resins & Chemicals Llc filed Critical Advansix Resins & Chemicals Llc
Publication of BR112022012216A2 publication Critical patent/BR112022012216A2/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1617—Organic compounds, e.g. phospholipids, fats
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/535—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
    • A61K31/5375—1,4-Oxazines, e.g. morpholine
    • A61K31/5377—1,4-Oxazines, e.g. morpholine not condensed and containing further heterocyclic rings, e.g. timolol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/24—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing atoms other than carbon, hydrogen, oxygen, halogen, nitrogen or sulfur, e.g. cyclomethicone or phospholipids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/44—Oils, fats or waxes according to two or more groups of A61K47/02-A61K47/42; Natural or modified natural oils, fats or waxes, e.g. castor oil, polyethoxylated castor oil, montan wax, lignite, shellac, rosin, beeswax or lanolin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/0056—Mouth soluble or dispersible forms; Suckable, eatable, chewable coherent forms; Forms rapidly disintegrating in the mouth; Lozenges; Lollipops; Bite capsules; Baked products; Baits or other oral forms for animals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/06—Ointments; Bases therefor; Other semi-solid forms, e.g. creams, sticks, gels
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/107—Emulsions ; Emulsion preconcentrates; Micelles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1611—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1617—Organic compounds, e.g. phospholipids, fats
    • A61K9/1623—Sugars or sugar alcohols, e.g. lactose; Derivatives thereof; Homeopathic globules
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1629—Organic macromolecular compounds
    • A61K9/1635—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1629—Organic macromolecular compounds
    • A61K9/1652—Polysaccharides, e.g. alginate, cellulose derivatives; Cyclodextrin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2013—Organic compounds, e.g. phospholipids, fats
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841—Filling excipients; Inactive ingredients
    • A61K9/4858—Organic compounds
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F7/00—Compounds containing elements of Groups 4 or 14 of the Periodic Table
    • C07F7/02—Silicon compounds
    • C07F7/08—Compounds having one or more C—Si linkages
    • C07F7/0834—Compounds having one or more O-Si linkage
    • C07F7/0838—Compounds with one or more Si-O-Si sequences

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Dispersion Chemistry (AREA)
  • Zoology (AREA)
  • Nutrition Science (AREA)
  • Physiology (AREA)
  • Organic Chemistry (AREA)
  • Dermatology (AREA)
  • Biochemistry (AREA)
  • Inorganic Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Emulsifying, Dispersing, Foam-Producing Or Wetting Agents (AREA)

Abstract

FORMULAÇÃO DE CUIDADO DE SAÚDE SÓLIDA, FORMULAÇÃO LÍQUIDA PARA CUIDADO DE SAÚDE, E EMULSÃO PARA CUIDADOS DE SAÚDE. Formulações de cuidados de saúde, incluindo tensoativos, ingrediente Ativo formulado como sólidos, líquidos ou emulsões inventivos. A presente divulgação fornece formulações de produtos de saúde, tais como: fármacos de prescrição, fármacos de venda livre; minerais, ervas e/ou suplementos vitamínicos; fármacos administrados em hospitais, clínicas, consultório médico e locais de cuidados paliativos; vacinas, tecidos, órgãos e transplantes de células e/ou enxertos e/ou infusões; e formulações de cuidados de feridas, incluindo unguentos tópicos, loções, produtos de limpeza, lenços, bandagens e curativos. O Ativo pode ser incluído nas formulações como um soluto, um solvente, uma partícula ou um componente imiscível em óleo da formulação. O Ativo pode ser incluído em comprimidos, cápsulas, tinturas, líquidos ou emulsões. As formulações de saúde inventivas incluem formulações adequadas para administração oral, tópica e/ou por injeção.
BR112022012216A 2019-12-20 2020-12-11 Formulação de cuidado de saúde sólida, formulação líquida para cuidado de saúde, e emulsão para cuidados de saúde BR112022012216A2 (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201962951943P 2019-12-20 2019-12-20
PCT/US2020/064692 WO2021126716A1 (en) 2019-12-20 2020-12-11 Surfactants for use in healthcare products

Publications (1)

Publication Number Publication Date
BR112022012216A2 true BR112022012216A2 (pt) 2022-09-13

Family

ID=74141956

Family Applications (1)

Application Number Title Priority Date Filing Date
BR112022012216A BR112022012216A2 (pt) 2019-12-20 2020-12-11 Formulação de cuidado de saúde sólida, formulação líquida para cuidado de saúde, e emulsão para cuidados de saúde

Country Status (12)

Country Link
US (1) US11633481B2 (pt)
EP (1) EP4076389A1 (pt)
JP (1) JP7346744B2 (pt)
KR (1) KR20220114639A (pt)
CN (1) CN115087430A (pt)
AU (1) AU2020407398B2 (pt)
BR (1) BR112022012216A2 (pt)
CA (1) CA3161693A1 (pt)
MX (1) MX2022007424A (pt)
MY (1) MY196955A (pt)
WO (1) WO2021126716A1 (pt)
ZA (1) ZA202207551B (pt)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN114555611B (zh) * 2019-08-22 2024-07-30 艾德凡斯化学公司 具有表面活性性质的氨基酸的硅氧烷衍生物
CN115087349A (zh) 2019-12-19 2022-09-20 艾德凡斯化学公司 用于农业产品的表面活性剂
US12054663B2 (en) 2019-12-19 2024-08-06 Advansix Resins & Chemicals Llc Surfactants for inks, paints, and adhesives
CN115103664A (zh) 2019-12-19 2022-09-23 艾德凡斯化学公司 用于个人护理和美容产品的表面活性剂
KR20220117910A (ko) 2019-12-20 2022-08-24 어드밴식스 레진즈 앤드 케미컬즈 엘엘씨 클리닝 제품용 계면활성제
JP7451717B2 (ja) 2019-12-31 2024-03-18 アドバンシックス・レジンズ・アンド・ケミカルズ・リミテッド・ライアビリティ・カンパニー 油及びガス生産のための界面活性剤
CN115428169A (zh) 2020-02-05 2022-12-02 艾德凡斯化学公司 用于电子产品的表面活性剂

Family Cites Families (49)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3624120A (en) 1969-12-22 1971-11-30 Procter & Gamble Quaternary ammonium salts of cyclic siloxane polymers
AT330930B (de) 1973-04-13 1976-07-26 Henkel & Cie Gmbh Verfahren zur herstellung von festen, schuttfahigen wasch- oder reinigungsmitteln mit einem gehalt an calcium bindenden substanzen
US4605509A (en) 1973-05-11 1986-08-12 The Procter & Gamble Company Detergent compositions containing sodium aluminosilicate builders
DE2433485A1 (de) 1973-07-16 1975-02-06 Procter & Gamble Zur verwendung in waschmitteln geeignete aluminosilikat-ionenaustauscher
US3929678A (en) 1974-08-01 1975-12-30 Procter & Gamble Detergent composition having enhanced particulate soil removal performance
DE3413571A1 (de) 1984-04-11 1985-10-24 Hoechst Ag, 6230 Frankfurt Verwendung von kristallinen schichtfoermigen natriumsilikaten zur wasserenthaertung und verfahren zur wasserenthaertung
DE3930344A1 (de) 1989-09-12 1991-03-14 Merck Patent Gmbh Silanderivate
US5041590A (en) 1990-01-04 1991-08-20 Dow Corning Corporation Quaternary ammonium functional siloxane surfactants
ATE267822T1 (de) 1998-10-30 2004-06-15 Merck Patent Gmbh Verfahren zur herstellung von luteolin und luteolin-derivaten
US6013683A (en) 1998-12-17 2000-01-11 Dow Corning Corporation Single phase silicone and water compositions
US6521580B2 (en) 2000-02-22 2003-02-18 General Electric Company Siloxane dry cleaning composition and process
KR101273907B1 (ko) 2004-07-02 2013-06-14 허니웰 인터내셔널 인코포레이티드 작용성 실록산 및 실란 그리고 이들의 비닐 공-중합체
US7632796B2 (en) 2005-10-28 2009-12-15 Dynaloy, Llc Dynamic multi-purpose composition for the removal of photoresists and method for its use
WO2007056424A2 (en) * 2005-11-07 2007-05-18 Penwest Pharmaceuticals, Co. Controlled-release emulsion compositions
DE102005056620A1 (de) 2005-11-25 2007-06-06 Merck Patent Gmbh Amphiphile Silane
US7622512B2 (en) 2005-12-21 2009-11-24 Bausch & Lomb Incorporated Cationic hydrophilic siloxanyl monomers
GB0611217D0 (en) 2006-06-08 2006-07-19 Dow Corning Amino-acid functional siloxanes,methods of preparation and applications
US20080152540A1 (en) * 2006-12-22 2008-06-26 Bausch & Lomb Incorporated Packaging solutions
US20090173912A1 (en) 2007-12-26 2009-07-09 Momentive Performance Materials Inc. Mixtures of hydrolysis resistant organomodified trisiloxane ionic surfactants
JP5760921B2 (ja) * 2010-10-14 2015-08-12 信越化学工業株式会社 アミノ酸変性オルガノポリシロキサンの製造方法
US20120295447A1 (en) 2010-11-24 2012-11-22 Air Products And Chemicals, Inc. Compositions and Methods for Texturing of Silicon Wafers
FI127433B (fi) 2011-06-14 2018-05-31 Pibond Oy Menetelmä siloksaanimonomeerien syntetisoimiseksi sekä näiden käyttö
US20130130508A1 (en) 2011-09-02 2013-05-23 Air Products And Chemicals, Inc. Compositions and Methods for Texturing of Silicon Wafers
CN102614808B (zh) 2012-03-08 2013-11-20 齐齐哈尔大学 以低碳链缩水甘油醚为连接基的乙酰胺二聚三硅氧烷表面活性剂的制备方法
US10053619B2 (en) 2013-03-14 2018-08-21 Flotek Chemistry, Llc Siloxane surfactant additives for oil and gas applications
JP6373271B2 (ja) 2013-09-19 2018-08-15 攝津製油株式会社 半導体基板用エッチング液
KR20150108143A (ko) 2014-03-17 2015-09-25 동우 화인켐 주식회사 결정성 실리콘 웨이퍼의 텍스쳐 에칭액 조성물 및 텍스쳐 에칭방법
CN104826140B (zh) * 2015-04-08 2018-07-03 中山大学 一种载药硅脂质超声造影剂的制备方法和应用
US9816026B2 (en) 2015-05-26 2017-11-14 Baker Hughes, LLC Methods of extracting hydrocarbons from subterranean formations
KR20170003414A (ko) * 2015-06-30 2017-01-09 (주)아모레퍼시픽 속붕해형 과립환 모발 세정용 조성물
WO2017011600A1 (en) * 2015-07-13 2017-01-19 Dr. Reddy's Laboratories, Ltd. Topical retinoid compositions
JP2017105753A (ja) 2015-12-04 2017-06-15 信越化学工業株式会社 両末端に異なる官能基を有する直鎖オルガノポリシロキサン、及びその製造方法
CN109196085B (zh) 2016-04-27 2021-03-30 美国陶氏有机硅公司 含有甲醇官能的三硅氧烷的洗涤剂组合物
US10577533B2 (en) 2016-08-28 2020-03-03 Linde Aktiengesellschaft Unconventional enhanced oil recovery
JP6990982B2 (ja) 2017-04-10 2022-01-12 信越化学工業株式会社 ポリシロキサンモノマー及びその製造方法
JP6803304B2 (ja) 2017-08-01 2020-12-23 信越化学工業株式会社 シロキサン化合物及びその製造方法
CN107698615A (zh) 2017-09-13 2018-02-16 常熟理工学院 一种氨基酸改性四硅氧烷表面活性剂及其制备方法
CN107602862A (zh) 2017-09-13 2018-01-19 常熟理工学院 一种氨基酸改性聚硅氧烷表面活性剂及其制备方法
CN107522726A (zh) 2017-09-13 2017-12-29 常熟理工学院 一种氨基酸改性三硅氧烷表面活性剂及其制备方法
CN107597019A (zh) * 2017-09-13 2018-01-19 常熟理工学院 一种Bola型氨基酸改性有机硅表面活性剂及其制备方法
CN107497365A (zh) 2017-09-13 2017-12-22 常熟理工学院 一种Gemini型氨基酸改性有机硅表面活性剂及其制备方法
WO2021003455A1 (en) 2019-07-02 2021-01-07 DeepMap Inc. Determining localization confidence of vehicles based on convergence ranges
CN114555611B (zh) * 2019-08-22 2024-07-30 艾德凡斯化学公司 具有表面活性性质的氨基酸的硅氧烷衍生物
CN115087349A (zh) 2019-12-19 2022-09-20 艾德凡斯化学公司 用于农业产品的表面活性剂
US12054663B2 (en) 2019-12-19 2024-08-06 Advansix Resins & Chemicals Llc Surfactants for inks, paints, and adhesives
CN115103664A (zh) 2019-12-19 2022-09-23 艾德凡斯化学公司 用于个人护理和美容产品的表面活性剂
KR20220117910A (ko) 2019-12-20 2022-08-24 어드밴식스 레진즈 앤드 케미컬즈 엘엘씨 클리닝 제품용 계면활성제
JP7451717B2 (ja) 2019-12-31 2024-03-18 アドバンシックス・レジンズ・アンド・ケミカルズ・リミテッド・ライアビリティ・カンパニー 油及びガス生産のための界面活性剤
CN115428169A (zh) 2020-02-05 2022-12-02 艾德凡斯化学公司 用于电子产品的表面活性剂

Also Published As

Publication number Publication date
US11633481B2 (en) 2023-04-25
JP2023507772A (ja) 2023-02-27
JP7346744B2 (ja) 2023-09-19
AU2020407398B2 (en) 2023-11-09
KR20220114639A (ko) 2022-08-17
ZA202207551B (en) 2023-12-20
MY196955A (en) 2023-05-12
CN115087430A (zh) 2022-09-20
AU2020407398A1 (en) 2022-08-18
US20210187110A1 (en) 2021-06-24
MX2022007424A (es) 2022-09-19
WO2021126716A1 (en) 2021-06-24
EP4076389A1 (en) 2022-10-26
CA3161693A1 (en) 2021-06-24

Similar Documents

Publication Publication Date Title
BR112022012216A2 (pt) Formulação de cuidado de saúde sólida, formulação líquida para cuidado de saúde, e emulsão para cuidados de saúde
BR112022017690A2 (pt) Formulação de cuidado de saúde sólida, formulação líquida para cuidado de saúde, e emulsão para cuidados de saúde
Thawabteh et al. Skin pigmentation types, causes and treatment—a review
Kim et al. Potential therapeutic applications of bee venom on skin disease and its mechanisms: A literature review
Irrera et al. Dietary management of skin health: the role of genistein
Garg et al. Comprehensive review on additives of topical dosage forms for drug delivery
Talat et al. Emulgel: An effective drug delivery system
Miastkowska et al. Nanoemulsion gel formulation optimization for burn wounds: Analysis of rheological and sensory properties
El-Say et al. Diacerein niosomal gel for topical delivery: development, in vitro and in vivo assessment
BR112019017018A2 (pt) formulações de canabinoides para o tratamento de dermatite e doenças de pele inflamatórias
Jurca et al. Formulation of topical dosage forms containing synthetic and natural anti-inflammatory agents for the treatment of rheumatoid arthritis
Abate et al. Keratinocytes migration promotion, proliferation induction, and free radical injury prevention by 3-hydroxytirosol
Vater et al. Lecithin-based nanoemulsions of traditional herbal wound healing agents and their effect on human skin cells
Talianu et al. Foray into concepts of design and evaluation of microemulsions as a modern approach for topical applications in acne pathology
CA2994331A1 (en) Transdermal formulations for delivery of capsaicinoids
Filipiuc et al. The Skin and Natural Cannabinoids–Topical and Transdermal Applications
ZA202301109B (en) Branched amino acid surfactants for use in healthcare products
Januszewski et al. Nutritional supplements for skin health—A review of what should be chosen and why
Frei et al. In Vitro and In Vivo Efficacy of Topical Dosage Forms Containing Self-Nanoemulsifying Drug Delivery System Loaded with Curcumin
Soulele et al. Milk as a medium for pediatric formulations: Experimental findings and regulatory aspects
KR102368646B1 (ko) 상온 유화 공정을 이용한 아토피 개선 로션
Vons et al. Market analysis of semisolid dosage forms registered in Ukraine and research of excipients included to their formulas
Gupta et al. Healing potential of propolis extract–Passiflora edulis seed oil emulgel against excisional wound: biochemical, histopathological, and cytokines level evidence
JP6240626B2 (ja) 抗アトピー性皮膚炎用組成物
Tatu et al. Formulation, preparation, physico-chemical, microbiological analysis and clinical uses of capsaicin microemulsions

Legal Events

Date Code Title Description
B06W Patent application suspended after preliminary examination (for patents with searches from other patent authorities) chapter 6.23 patent gazette]